MedPath

A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine

Not Applicable
Completed
Conditions
Anaphylaxis
Interventions
Registration Number
NCT01432522
Lead Sponsor
Siriraj Hospital
Brief Summary

This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.

Detailed Description

Patients are reluctant to use Epipen® on emergency basis, perhaps because of improperly training, hesitancy and fear of needle. Other route of administration of epinephrine (EPI) may be more benefit such as intranasal route.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  1. Healthy subjects
  2. 18-30 years-old
Exclusion Criteria
  1. Pregnancy
  2. Subjected who use current medication that interfere with result of plasma epinephrine level such as pseudoephedrine

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
epinephrine IN, epinephrine IM, saline INEpinephrine1. Intranasal saline 2. Intramuscular epinephrine 3. Intranasal epinephrine
Primary Outcome Measures
NameTimeMethod
Composite of Pharmacokinetics of epinephrinepredose, 5 , 10, 15, 20, 30, 45, 60, 90, 120, 180 minutes post-dose

Cmax, Area Under Curve, Tmax of epinephrine compare between 0.3 mg intramuscular and 5 mg intranasal route

Secondary Outcome Measures
NameTimeMethod
Numbers of participants with adverse events as a measure of safety and tolerability1 year

Any side effects from such administration such as bad smelling, sorethroat.

Trial Locations

Locations (1)

Facaulty of Medicine, Siriraj Hospital

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath